Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Lowenburg

Forensic Psychiatry New Orleans, LA Medical Doctor

NPI 1770872285 CMS profile 1386627

1440 Canal St, Tb-53, New Orleans, LA 70112

Open in the dashboard

General payments

$1,495

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Lowenburg of New Orleans, LA is reported in the CMS Open Payments database as having received $1,495 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Forensic Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $316 12
2024 General $432 19
2023 General $291 12
2022 General $89 4
2021 General $69 4
2020 General $65 4
2019 General $233 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Lowenburg
  • Forensic Psychiatry median
  • Middle half of Forensic Psychiatry
  • National median

In program year 2025, general payments to Benjamin Lowenburg were reported at $316. Among 86 Forensic Psychiatry profiles paid that year, the median was $125 and the middle half received between $34 and $306.

Show as a table
Year Benjamin Lowenburg Forensic Psychiatry median Middle half National median
2019 $233 $143 $61–$431 $163
2020 $65 $112 $36–$301 $114
2021 $69 $113 $38–$343 $132
2022 $89 $113 $67–$475 $149
2023 $291 $139 $66–$415 $160
2024 $432 $117 $36–$341 $164
2025 $316 $125 $34–$306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alkermes, Inc. $620 26 payments
  2. Teva Pharmaceuticals USA, Inc. $180 7 payments
  3. BioXcel Therapeutics, Inc. $153 6 payments
  4. Otsuka America Pharmaceutical, Inc. $152 8 payments
  5. Indivior Inc. $140 7 payments
  6. Neurocrine Biosciences, Inc. $127 7 payments
  7. Sunovion Pharmaceuticals Inc. $110 7 payments
  8. Janssen Pharmaceuticals, Inc $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,495 69 payments
Products named General payments · program years 2019–2025
  1. ARISTADA Cns $583 24 payments
  2. ARISTADA Cns $583 24 payments
  3. ARISTADA Cns $507 21 payments
  4. ARISTADA Cns $507 21 payments
  5. LYBALVI $472 18 payments
  6. ARISTADA INITIO $187 9 payments
  7. IGALMI $153 6 payments
  8. UZEDY $153 6 payments
  9. PERSERIS $140 7 payments
  10. LATUDA $110 7 payments
  11. Other $542 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Forensic Psychiatry in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record